Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Operating Income by Segment

536 Followers

Operating Income by Segment

Bio-Techne reported operating income by segment of $83.20M in Q1 FY2027, down 14.3% from Q4 FY2026 and up 7.1% year over year. The highest value was $103.91M in Q3 FY2025.

Reports each segment’s profit after operating costs, revealing which parts of the business cover their overhead and contribute to core profitability. Tracking these trends shows whether growth is coming from efficient, scalable operations or from lower-margin areas that may need restructuring.

$0.00$20.00M$40.00M$60.00M$80.00M$100.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Protein Sciences' operating income shows consistent seasonality—repeated strong Q1 peaks and recurring Q3 troughs—while peak Q1s have crept higher through 2025–26, but Q3 lows have deepened, producing lumpy quarterly results. That pattern suggests demand tied to funding/ordering cycles rather than structural margin expansion; expect full-year stability but volatile quarter-to-quarter guidance risk. Investors should prioritize year-over-year and trailing-12-month trends and management commentary on order visibility rather than any single quarter.

TECH Operating Income by Segment

PeriodProtein Sciences
Q1 FY2027Sep 30, 2026$83.20M
Q4 FY2026Jun 30, 2026$97.07M
Q3 FY2026Mar 31, 2026$100.00M
Q2 FY2026Dec 31, 2025$84.61M
Q1 FY2026Sep 30, 2025$77.71M
Q4 FY2025Jun 30, 2025$98.79M
Q3 FY2025Mar 31, 2025$103.91M
Q2 FY2025Dec 31, 2024$87.11M
Q1 FY2025Sep 30, 2024$80.54M
Q4 FY2024Jun 30, 2024$92.00M
Q3 FY2024Mar 31, 2024$94.83M
Q2 FY2024Dec 31, 2023$79.59M
Q1 FY2024Sep 30, 2023$88.36M
Q4 FY2023Jun 30, 2023$99.65M
Q3 FY2023Mar 31, 2023$98.76M
Q2 FY2023Dec 31, 2022$89.34M
Q1 FY2023Sep 30, 2022$85.94M
Q4 FY2022Jun 30, 2022$97.49M
Q3 FY2022Mar 31, 2022$96.75M
Q2 FY2022Dec 31, 2021$93.28M
Q1 FY2022Sep 30, 2021$90.10M
Q4 FY2021Jun 30, 2021$90.44M
Q3 FY2021Mar 31, 2021$88.39M
Q2 FY2021Dec 31, 2020$80.25M
Q1 FY2021Sep 30, 2020$70.35M

Related KPIs